This license agreement completes the roll out of the Innocap family of replication products that was launched in July 2007. Innocap has developed a diverse suite of funds, each of which has a clearly defined objective. Salto MSCI HF Composite Synthetic Tracker aims at minimizing the tracking error with the reference index while Verso MSCI HF Composite Short Synthetic Tracker offers a short version for hedging purposes. Dosalto MSCI HF Composite Leveraged Synthetic Tracker will soon be launched to offer a 2x leveraged version of Salto. All products are offered to accredited institutional investors through a Malta-based vehicle, for which Innocap acts as investment advisor.
Martin Gagnon, co-CEO of Innocap, said: Innocap developed what we believe to be the most advanced algorithm currently available on the market to track HF indices using liquid factors. We use a sophisticated filter specifically designed for tracking complex trajectories, allowing the products to be very robust and highly adaptable to changes in market conditions.
